ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 11

PAD4-Independent Interaction of ACPA with Nuclear Antigens in Apoptotic Cells and Neutrophil Extracellular Traps (NETs) Defines a Subset of Autoantibodies

Gustaf Wigerblad1, Katy A. Lloyd1, Peter Sahlström2, Karine Chemin2, Johanna Steen2, Philip J. Titcombe2,3, Diana Zhou2, Ragnhild Stålesen1, Bianka Marklein4, Elena Ossipova2, Johan Rönnelid5, Luca Piccoli6, Antonio Lanzavecchia6, Daniel L. Mueller3, Karl Skriner4, Lars Klareskog2, Fredrik Wermeling1, Vivianne Malmström2 and Caroline Grönwall7, 1Rheumatology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Rheumatology Unit, Dept. of Medicine, Karolinska Institutet, Stockholm, Sweden, 3The Center for Immunology, Dept. of Medicine, University of Minnesota Medical School, Minneapolis, MN, 4Dept. of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany, 5Dept. of Immunology Genetics and Pathology, Uppsala University, Uppsala, Sweden, 6Università della Svizzera italiana, Institute for Research in Biomedicine, Bellinzona, Switzerland, 7Dep. of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ACPA, ANA, Anti-CCP antibodies and rheumatoid arthritis (RA), Neutrophil Extracellular Traps

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid arthritis (RA) associated anti-citrullinated protein autoantibodies (ACPA) bind a wide range of citrullinated proteins with high cross-reactivity. Recent findings suggest that certain, but not all, ACPA may have pathogenic properties. Citrullination occurs during physiological processes such as apoptosis, neutrophil extracellular trap (NET) formation and histone modifications, yet little is known about the interaction of ACPA with these antigens. Since uncleared apoptotic cells and NET products have been postulated to be central sources of autoantigen and immunostimulation in autoimmune disease, we sought to determine the anti-nuclear and anti-neutrophil ACPA reactivity.

Methods:

We screened a total of 11 recombinant single B-cell isolated RA monoclonal human ACPA-IgG, derived from different cellular origin and compartments, for binding to full-length citrullinated nuclear antigens including histones and hnRNPs by ELISA. All ACPA mAbs have previously been confirmed anti-CCP2 reactive, with specific and extensive cit-peptide reactivity demonstrated by ELISA and antigen-arrays. ACPA apoptotic cell binding was determined by flow cytometry and immunoprecipitation. Immunofluorescence was utilized for primary human neutrophil and the Ecom-G murine neutrophil systems. ACPA binding to Ecom-G cells was also evaluated with flow cytometry. Anti-nuclear antibody reactivity (ANA) was evaluated with standard HEp-2 tests. CRISPR-Cas9 technology was used to generate peptidylarginine deiminase type 4 (PAD4) KO neutrophils and chlor-amidine (Cl-A) was used as pharmacological inhibition of PAD enzymes.

Results:

We could observe that a subset of three monoclonal ACPA (37CEPT2C04, 37CEPT1G09, 1325:01B09) had high ANA reactivity and high binding to apoptotic cells. This did to some extent correlate with ELISA reactivity patterns to full-length citrullinated histones, but less so to citrullinated hnRNPs. Indeed, immunoprecipitations from apoptotic cell lysates revealed citrullinated histones as primary targets. One of the ACPA (1325:01B09) had a high capacity to induce IL-8 release from human peripheral mononuclear cells in plate-bound immune complexes with citrullinated histones. Importantly, all the anti-nuclear ACPA mAbs bound strongly to activated murine and human neutrophils and NETs. However, we also found two mAbs (1325:01C03 and BVCA1) in a second NET-reactive ACPA subset with contrasting perinuclear neutrophil binding and cross-reactivity patterns more towards the cytoplasmic antigens vimentin and alpha-enolase. Notably, CRISPR-Cas9 KO studies and pharmacological PAD inhibition showed that the cytoplasmic NET binding was fully dependent on PAD4 while the nuclear and histone mediated NET-reactivity was independent of PAD4.

Conclusion:

When investigating monoclonal ACPA, we identified distinct subsets based on binding to neutrophils and NETs with either a nuclear pattern or a cytoplasmic perinuclear pattern. Importantly, only the cytoplasmic anti-neutrophil ACPA binding was PAD4 dependent. This may have important functional impact and provide insights in RA pathogenesis.


Disclosure: G. Wigerblad, None; K. A. Lloyd, None; P. Sahlström, None; K. Chemin, None; J. Steen, None; P. J. Titcombe, None; D. Zhou, None; R. Stålesen, None; B. Marklein, None; E. Ossipova, None; J. Rönnelid, None; L. Piccoli, None; A. Lanzavecchia, None; D. L. Mueller, None; K. Skriner, None; L. Klareskog, None; F. Wermeling, None; V. Malmström, None; C. Grönwall, None.

To cite this abstract in AMA style:

Wigerblad G, Lloyd KA, Sahlström P, Chemin K, Steen J, Titcombe PJ, Zhou D, Stålesen R, Marklein B, Ossipova E, Rönnelid J, Piccoli L, Lanzavecchia A, Mueller DL, Skriner K, Klareskog L, Wermeling F, Malmström V, Grönwall C. PAD4-Independent Interaction of ACPA with Nuclear Antigens in Apoptotic Cells and Neutrophil Extracellular Traps (NETs) Defines a Subset of Autoantibodies [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/pad4-independent-interaction-of-acpa-with-nuclear-antigens-in-apoptotic-cells-and-neutrophil-extracellular-traps-nets-defines-a-subset-of-autoantibodies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pad4-independent-interaction-of-acpa-with-nuclear-antigens-in-apoptotic-cells-and-neutrophil-extracellular-traps-nets-defines-a-subset-of-autoantibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology